2E4R
| |
2EJK
| |
3E20
| Crystal structure of S.pombe eRF1/eRF3 complex | 分子名称: | Eukaryotic peptide chain release factor GTP-binding subunit, Eukaryotic peptide chain release factor subunit 1 | 著者 | Cheng, Z, Lim, M, Kong, C, Song, H. | 登録日 | 2008-08-05 | 公開日 | 2009-05-19 | 最終更新日 | 2023-11-01 | 実験手法 | X-RAY DIFFRACTION (3.5 Å) | 主引用文献 | Structural insights into eRF3 and stop codon recognition by eRF1 Genes Dev., 23, 2009
|
|
2EMU
| |
2EN5
| |
2EH2
| |
2PC8
| E292Q mutant of EXO-B-(1,3)-Glucanase from Candida Albicans in complex with two separately bound glucopyranoside units at 1.8 A | 分子名称: | Hypothetical protein XOG1, beta-D-glucopyranose | 著者 | Cutfield, S.M, Cutfield, J.F, Patrick, W.M. | 登録日 | 2007-03-29 | 公開日 | 2008-04-01 | 最終更新日 | 2024-10-30 | 実験手法 | X-RAY DIFFRACTION (1.8 Å) | 主引用文献 | Carbohydrate binding sites in Candida albicans exo-beta-1,3-glucanase and the role of the Phe-Phe 'clamp' at the active site entrance. Febs J., 277, 2010
|
|
2LDS
| |
2PF0
| |
3IIT
| Factor XA in complex with a cis-1,2-diaminocyclohexane derivative | 分子名称: | 7-chloro-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-{[(5-methyl-5,6-dihydro-4H-pyrrolo[3,4-d][1,3]thiazol-2-yl)carbonyl]amino}cyclohexyl]isoquinoline-3-carboxamide, Activated factor Xa heavy chain, CALCIUM ION, ... | 著者 | Suzuki, M. | 登録日 | 2009-08-03 | 公開日 | 2010-08-04 | 最終更新日 | 2024-10-30 | 実験手法 | X-RAY DIFFRACTION (1.8 Å) | 主引用文献 | Design, synthesis, and SAR of cis-1,2-diaminocyclohexane derivatives as potent factor Xa inhibitors. Part II: exploration of 6-6 fused rings as alternative S1 moieties. Bioorg.Med.Chem., 17, 2009
|
|
5B5O
| Crystal structure of the catalytic domain of MMP-13 complexed with N-phenyl-4-((4H-1,2,4-triazol-3-ylsulfanyl)methyl)-1,3-thiazol-2-amine | 分子名称: | 1,2-ETHANEDIOL, CALCIUM ION, Collagenase 3, ... | 著者 | Oki, H, Tanaka, Y. | 登録日 | 2016-05-13 | 公開日 | 2017-01-18 | 最終更新日 | 2023-11-08 | 実験手法 | X-RAY DIFFRACTION (1.2 Å) | 主引用文献 | Discovery of Novel, Highly Potent, and Selective Matrix Metalloproteinase (MMP)-13 Inhibitors with a 1,2,4-Triazol-3-yl Moiety as a Zinc Binding Group Using a Structure-Based Design Approach J. Med. Chem., 60, 2017
|
|
5B5P
| Crystal structure of the catalytic domain of MMP-13 complexed with 4-oxo-N-(3-(2-(1H-1,2,4-triazol-3-ylsulfanyl)ethoxy)benzyl)-3,4-dihydroquinazoline-2-carboxamide | 分子名称: | 4-oxo-N-{3-[2-(1H-1,2,4-triazol-3-ylsulfanyl)ethoxy]benzyl}-3,4-dihydroquinazoline-2-carboxamide, CALCIUM ION, Collagenase 3, ... | 著者 | Oki, H, Tanaka, Y. | 登録日 | 2016-05-13 | 公開日 | 2017-01-18 | 最終更新日 | 2023-11-08 | 実験手法 | X-RAY DIFFRACTION (1.6 Å) | 主引用文献 | Discovery of Novel, Highly Potent, and Selective Matrix Metalloproteinase (MMP)-13 Inhibitors with a 1,2,4-Triazol-3-yl Moiety as a Zinc Binding Group Using a Structure-Based Design Approach J. Med. Chem., 60, 2017
|
|
4P5I
| Crystal structure of the chemokine binding protein from orf virus | 分子名称: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Chemokine binding protein | 著者 | Counago, R.M, Krause, K.L. | 登録日 | 2014-03-17 | 公開日 | 2015-07-15 | 最終更新日 | 2023-12-27 | 実験手法 | X-RAY DIFFRACTION (2.25 Å) | 主引用文献 | Structures of Orf Virus Chemokine Binding Protein in Complex with Host Chemokines Reveal Clues to Broad Binding Specificity. Structure, 23, 2015
|
|
1BAV
| |
8GOH
| |
8GOI
| |
8II1
| Crystal structure of V30M-TTR in complex with BID | 分子名称: | Benziodarone, Transthyretin | 著者 | Yokoyama, T. | 登録日 | 2023-02-24 | 公開日 | 2023-06-28 | 最終更新日 | 2023-11-08 | 実験手法 | X-RAY DIFFRACTION (1.907 Å) | 主引用文献 | Benziodarone and 6-hydroxybenziodarone are potent and selective inhibitors of transthyretin amyloidogenesis. Bioorg.Med.Chem., 90, 2023
|
|
8II3
| Crystal structure of V30M-TTR in complex with 6-hydroxy BID | 分子名称: | Transthyretin, [3,5-bis(iodanyl)-4-oxidanyl-phenyl]-(2-ethyl-6-oxidanyl-1-benzofuran-3-yl)methanone | 著者 | Yokoyama, T. | 登録日 | 2023-02-24 | 公開日 | 2023-06-28 | 最終更新日 | 2024-05-29 | 実験手法 | X-RAY DIFFRACTION (1.399 Å) | 主引用文献 | Benziodarone and 6-hydroxybenziodarone are potent and selective inhibitors of transthyretin amyloidogenesis. Bioorg.Med.Chem., 90, 2023
|
|
8II2
| Crystal structure of V30M-TTR in complex with BBM | 分子名称: | CALCIUM ION, Transthyretin, [3,5-bis(bromanyl)-4-oxidanyl-phenyl]-(2-ethyl-1-benzofuran-3-yl)methanone | 著者 | Yokoyama, T. | 登録日 | 2023-02-24 | 公開日 | 2023-06-28 | 最終更新日 | 2024-05-29 | 実験手法 | X-RAY DIFFRACTION (1.798 Å) | 主引用文献 | Benziodarone and 6-hydroxybenziodarone are potent and selective inhibitors of transthyretin amyloidogenesis. Bioorg.Med.Chem., 90, 2023
|
|
8II4
| Crystal structure of V30M-TTR in complex with 6-hydroxy BBM | 分子名称: | Transthyretin, [3,5-bis(bromanyl)-4-oxidanyl-phenyl]-(2-ethyl-6-oxidanyl-1-benzofuran-3-yl)methanone | 著者 | Yokoyama, T. | 登録日 | 2023-02-24 | 公開日 | 2023-06-28 | 最終更新日 | 2024-05-29 | 実験手法 | X-RAY DIFFRACTION (1.499 Å) | 主引用文献 | Benziodarone and 6-hydroxybenziodarone are potent and selective inhibitors of transthyretin amyloidogenesis. Bioorg.Med.Chem., 90, 2023
|
|
8HRH
| SN-131/1B2 anti-MUC1 antibody with a glycopeptide | 分子名称: | 1-ACETYL-L-PROLINE, 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL, ALANINE, ... | 著者 | Wakui, H, Horidome, C, Yao, M, Ose, T, Nishimura, S.-I. | 登録日 | 2022-12-15 | 公開日 | 2023-08-30 | 実験手法 | X-RAY DIFFRACTION (2.07 Å) | 主引用文献 | Structural and molecular insight into antibody recognition of dynamic neoepitopes in membrane tethered MUC1 of pancreatic cancer cells and secreted exosomes. Rsc Chem Biol, 4, 2023
|
|
8IG1
| |
7W9Q
| Crystal structure of V30M-TTR in complex with naringenin derivative-14 | 分子名称: | (2~{R})-2-(3-chloranyl-4-oxidanyl-phenyl)-5,7-bis(oxidanyl)-2,3-dihydrochromen-4-one, CALCIUM ION, Transthyretin | 著者 | Katayama, W, Shimane, A, Nabeshima, Y, Yokoyama, T, Mizuguchi, M. | 登録日 | 2021-12-10 | 公開日 | 2022-12-14 | 最終更新日 | 2023-11-29 | 実験手法 | X-RAY DIFFRACTION (1.599 Å) | 主引用文献 | Chlorinated Naringenin Analogues as Potential Inhibitors of Transthyretin Amyloidogenesis. J.Med.Chem., 65, 2022
|
|
7W9R
| Crystal structure of V30M-TTR in complex with naringenin derivative-18 | 分子名称: | (2~{R})-2-[3,5-bis(chloranyl)-4-oxidanyl-phenyl]-5,7-bis(oxidanyl)-2,3-dihydrochromen-4-one, Transthyretin | 著者 | Katayama, W, Shimane, A, Nabeshima, Y, Yokoyama, T, Mizuguchi, M. | 登録日 | 2021-12-10 | 公開日 | 2022-12-14 | 最終更新日 | 2023-11-29 | 実験手法 | X-RAY DIFFRACTION (1.997 Å) | 主引用文献 | Chlorinated Naringenin Analogues as Potential Inhibitors of Transthyretin Amyloidogenesis. J.Med.Chem., 65, 2022
|
|
4EH3
| Human p38 MAP kinase in complex with NP-F2 and RL87 | 分子名称: | Mitogen-activated protein kinase 14, NARINGENIN, N~4~-cyclopropyl-2-phenylquinazoline-4,7-diamine | 著者 | Over, B, Gruetter, C, Waldmann, H, Rauh, D. | 登録日 | 2012-04-02 | 公開日 | 2012-12-05 | 最終更新日 | 2023-09-13 | 実験手法 | X-RAY DIFFRACTION (2.4 Å) | 主引用文献 | Natural-product-derived fragments for fragment-based ligand discovery. Nat Chem, 5, 2012
|
|